April 2009

Agile Sciences' technology is spotlighted in a front page article in The News and Observer: "Slime-fighting molecules may rearm antibiotics"

March 2009

Agile Sciences' co-founders discuss Agile's anti-biofilm compounds in a Washington Post article: "Scientists Learning to Target Bacteria Where They Live"

March 2009

Agile Sciences is awarded a $50,000 Company Inception Loan by the North Carolina Biotechnology Center.

February 2009

Agile Sciences' technology is featured on the Science Magazine website, in an article entitled "Sponging Away Antibiotic Resistance"

More News...

Agile Sciences founders John Cavanagh and Christian Melander analyze the results of anti-biofilm screening tests.

The co-founders of Agile Sciences have developed compounds that can disperse colonies of bacteria called biofilms. These compounds have applications in the areas of medicine, agriculture, and industry.

Biofilms that form in the human body are up to ten thousand times more resistant to antibiotics and immune systems than free-floating bacteria, making them very difficult to treat medically. In agriculture, every year billions of dollars of crops are lost due to the formation of biofilms. Industrial needs for effective biofilm dispersion include surface coatings and cleansing products.

Agile Sciences' technology addresses problems associated with biofilm formation through the use of proprietary non-toxic organic compounds.